原文摘录：Antisense oligonucleotides (ASOs) are versatile disease-modifying therapies for genetic diseases. An accelerated US Food and Drug Administration (FDA) pathway enables ASO treatment trial initiation in an individual within a year.
据美联社预测，民主党在美国中期选举中赢得至少237个众议院席位和至少54个参议院席位，计划推动逆转Medicaid与ACA削减、恢复已到期增强型补贴并压低保费与药价。KFF研究者预计2027年ACA基准计划保费平均上涨13%，新国会1月就任时多数州仍处参保登记期。任何立法需特朗普签署，民主党还计划对药企秘密定价协议、疫苗建议调整及保险预授权拒批等展开监督调查。
FDA CDRH发布早期预警，通报潜在高风险器械问题：Compact Medical对部分批次ButterflyBVM一次性球囊面罩（BVM）复苏器发出紧急医疗器械召回通知，建议移除000109–000117批次，000081–000108批次须每次使用前完成使用前测试。
关注理由：FDA CDRH以Early Alert标记该潜在高风险器械问题，区分需移除批次与仅需使用前测试的批次，可据此跟踪急救通气器械的受影响范围与后续监管更新。
FDA 于2026年10月30日发布安全通告，多起报告称1.5–2.5岁幼儿食用 Once Upon a Farm Tractor Wheels 有机幼儿软烤棒后发生完全气道阻塞、无法呼吸，建议消费者勿购买或喂食并立即丢弃。
关注理由：FDA 报告多名1.5–2.5岁幼儿食用该软烤棒后发生常规急救难以解除的完全气道阻塞，且产品经全美主要零售渠道销售，属需持续跟踪更新的母婴食品安全预警。
原文摘录：CDRH is issuing this Early Alert to notify the public of a potentially high-risk device issue. The FDA will keep the public informed and update this web page as significant new information becomes available. Affected Product The FDA is aware that B. … Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program
关注理由：这条肾脏病学资料适合作为深入阅读入口，尤其要关注研究方法与结论是否匹配。
原文摘录：This recall involves removing certain devices from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it. … Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program
关注理由：这篇血液病学资料可用于了解领域进展，研究设计、结果和局限性值得一起阅读。
原文摘录：This recall involves implementing additional recommendations on the use of the StatStrip Glucose Hospital Meter System while awaiting a software update. … 10/20/2026 The FDA issued a communication notifying the public of a Class I Recall
关注理由：这篇内分泌与代谢内容涉及具体研究方向，原文中的样本、结局和限制有助于理解其价值。
原文摘录：CDRH is issuing this Early Alert to notify the public of a potentially high-risk device issue. The FDA will keep the public informed and update this web page as significant new information becomes available. … Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program
关注理由：这条呼吸病学内容涉及相关临床或研究问题，建议查看原文中的方法与适用范围。
原文摘录：Summary Company Announcement Date: October 21, 2026 FDA Publish Date: October 21, 2026 Product Type: Animal & Veterinary Drugs Reason for Announcement: Recall Reason Description Potential Potency Issues Company Name: Wedgewood Pharmacy, LLC. … Company Contact Information Consumers: Sedgwick 866-562-5931
原文摘录：CDRH is issuing this Early Alert to notify the public of a potentially high-risk device issue. The FDA will keep the public informed and update this web page as significant new information becomes available. … Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program
关注理由：这篇儿科学内容涉及具体研究方向，原文中的样本、结局和限制有助于理解其价值。
原文摘录：October 20, 2026 The U.S. Food and Drug Administration (FDA) is alerting health care providers about an import alert for certain medical devices manufactured in Japan by Olympus Medical Systems Corporation (Olympus) and its subsidiaries. … Additional Resources Import Alert 89-04 [10/19/2026] FDA Issues Two Warning Letters to Leading Manufacturer of Endoscopes [01/10/2023] Warning Letters Olympus Medical Systems Corporation Warning Letter [10/07/2026] Olympus Medical Systems Corporation Warning Letter (Hinode) [03/15/2023] Olympus Medical Systems Corporation Warning Letter (Hachioji-shi) [12/12/2022] Aizu Olympus Warning Letter [11/02/2022] Infections Associated with Reprocessed Duodenoscopes [06/30/2022] Infections Associated with Reprocessed Urological Endoscopes - Letter to Health Care Providers [04/01/2021]
关注理由：这条呼吸病学内容涉及相关临床或研究问题，建议查看原文中的方法与适用范围。
原文摘录：CDRH is issuing this Early Alert to notify the public of a potentially high-risk device issue. The FDA will keep the public informed and update this web page as significant new information becomes available. … Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program
关注理由：这条儿科学资料涉及具体临床问题，研究人群、方法和结局指标可以结合原文进一步查看。